[EN] SUBSTITUTED FNO (2-[FURAN-2-YL] NAPHTHALEN-1-OL) DERIVATIVES AS ANTI-CANCER AGENTS<br/>[FR] DÉRIVÉS DE FNO (2-[FURANE-2-YL] NAPHTHALÈNE-1-OL) SUBSTITUÉS UTILISÉS COMME AGENTS ANTICANCÉREUX
申请人:UNIV NORTH CAROLINA
公开号:WO2010080414A3
公开(公告)日:2010-11-04
Antitumor Agents. 266. Design, Synthesis, and Biological Evaluation of Novel 2-(Furan-2-yl)naphthalen-1-ol Derivatives as Potent and Selective Antibreast Cancer Agents
作者:Yizhou Dong、Qian Shi、Yi-Nan Liu、Xiang Wang、Kenneth F. Bastow、Kuo-Hsiung Lee
DOI:10.1021/jm9001567
日期:2009.6.11
In a continuing study, we explored how the individual rings in neo-tanshinlactone (1) influence its potent and selective in vitro antibreast cancer activity. Accordingly, we discovered a novel class of antibreast cancer agents, 2-(furan-2-yl)naphthalen-1-ol derivatives, based on an active C-ring opened model compound S. Further optimization led to 18 and 21, which showed decreased cytotoxic potency but better selectivity than neo-tanshinlactone analogue 2. Interestingly, 20 showed broad cytotoxicity against human cancer cell lines.